HYPERAMYLASEMIA IN ASYMPTOMATIC HIV PATIENTS

Authors
Citation
Y. Foo et P. Konecny, HYPERAMYLASEMIA IN ASYMPTOMATIC HIV PATIENTS, Annals of clinical biochemistry, 34, 1997, pp. 259-262
Citations number
11
Categorie Soggetti
Biology,"Medical Laboratory Technology
ISSN journal
00045632
Volume
34
Year of publication
1997
Part
3
Pages
259 - 262
Database
ISI
SICI code
0004-5632(1997)34:<259:HIAHP>2.0.ZU;2-D
Abstract
We studied serum amylase and its isoenzymes prospectively in 163 conse cutive asymptomatic patients, 149 men and 14 women, infected with HIV and attending an HIV out-patient clinic. Six patients were receiving d ideoxyinosine (DDI), a drug known to cause pancreatitis. No patient, h owever, had clinical signs suggestive of pancreatitis. Serum total amy lase was increased in 39 of 163 patients (24%), in 11 of whom (28%), t his was due to increased pancreatic (P) isoamylase alone, in 17 (42%) it was due to salivary (S) type alone and in six (17%) it was due to i ncrease of both P and S fractions. In five patients (13%), macroamylas e was detected. Pancreatic amylase was elevated in four of the six pat ients on DDI. The remaining two had macroamylase. Our results show tha t asymptomatic hyperamylasaemia is a common finding in HIV patients an d that it appears to be heterogenous, i.e. elevation may be due to inc rease in P or S, both enzyme fractions or macroamylase. The high incid ence of macroamylasaemia in HIV patients was an unexpected finding.